Cargando…

Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial

IMPORTANCE: There are few published studies prospectively assessing pharmacological interventions that may delay prostate cancer progression in patients undergoing active surveillance (AS). OBJECTIVE: To compare the efficacy and safety of enzalutamide monotherapy plus AS vs AS alone in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shore, Neal D., Renzulli, Joseph, Fleshner, Neil E., Hollowell, Courtney M. P., Vourganti, Srinivas, Silberstein, Jonathan, Siddiqui, Rizwan, Hairston, John, Elsouda, Dina, Russell, David, Cooperberg, Matthew R., Tomlins, Scott A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204619/ https://www.ncbi.nlm.nih.gov/pubmed/35708696 http://dx.doi.org/10.1001/jamaoncol.2022.1641

Ejemplares similares

Reply to Juan Gómez Rivas, Giorgio Gandaglia, and Francesco Montorsi’s Letter to the Editor re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Enzalutamide Monotherapy vs Active Surveillance in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128–36
por: Shore, Neal D.
Publicado: (2022)

A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design
por: Freedland, Stephen J, et al.
Publicado: (2021)

The Effects of Enzalutamide Monotherapy on Multiparametric 3T MR Imaging in Prostate Cancer
por: Van der Roest, Rosanne CV., et al.
Publicado: (2016)

Re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Active Surveillance plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128–36: Let’s Not Go Back in Time! What Have We Learned in the Treatment of Localized Prostate Cancer? Applicability of the ENACT Randomized Clinical Trial in Clinical Practice
por: Gómez Rivas, Juan, et al.
Publicado: (2022)

Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
por: Lara, Pedro C., et al.
Publicado: (2022)

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
por: Ju, Andrew W, et al.
Publicado: (2013)

Dental Enactments
Publicado: (1896)

Enacting Bioethics
por: Laurie, Graeme T.
Publicado: (2020)

Enactive Memory
por: Brouillet, Denis
Publicado: (2020)

Enacting Gender: An Enactive-Ecological Account of Gender and Its Fluidity
por: Albarracin, Mahault, et al.
Publicado: (2022)

Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome
por: Vicente, Alana, et al.
Publicado: (2020)

Predictors of residual pulmonary vascular obstruction after anticoagulation monotherapy in patients with intermediate-risk pulmonary embolism
por: Chang, Youjin, et al.
Publicado: (2021)

Phase Ib Study of the BET Inhibitor GS-5829 as Monotherapy and Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Aggarwal, Rahul, et al.
Publicado: (2022)

Short-term enzalutamide treatment for the potential remission of active surveillance or intermediate-risk prostate cancer: a case study, review, and the need for a clinical trial
por: Moyad, Mark A, et al.
Publicado: (2014)

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom
por: Dunst, Jürgen, et al.
Publicado: (2022)

Comparison of Hypomethylator Monotherapy with Hypomethylator plus Chemotherapy for Intermediate/High-Risk MDS or AML: A Meta-Analysis
por: Ji, Jiang, et al.
Publicado: (2020)

Reflections on the enactment of Medicare and Medicaid
por: Cohen, Wilbur J.
Publicado: (1985)

An enactive account of placebo effects
por: Ongaro, Giulio, et al.
Publicado: (2017)

Enactive Pragmatism and Ecological Psychology
por: Crippen, Matthew
Publicado: (2020)

Placebo From an Enactive Perspective
por: Arandia, Iñigo R., et al.
Publicado: (2021)

The Enacted Ethics of Self-injury
por: Chappell, Zsuzsanna
Publicado: (2022)

Enacting Plant-Inspired Robotics
por: Lee, Jonny, et al.
Publicado: (2022)

Health and Illness as Enacted Phenomena
por: Svenaeus, Fredrik
Publicado: (2021)

Clinical Pharmacokinetic Studies of Enzalutamide
por: Gibbons, Jacqueline A., et al.
Publicado: (2015)

Risk for stroke and myocardial infarction with abiraterone versus enzalutamide in metastatic prostate cancer patients
por: Kulkarni, A.A., et al.
Publicado: (2021)

Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
por: Armstrong, Andrew J., et al.
Publicado: (2022)

Association of Chemotherapy, Enzalutamide, Abiraterone, and Radium 223 With Cognitive Function in Older Men With Metastatic Castration-Resistant Prostate Cancer
por: Alibhai, Shabbir M. H., et al.
Publicado: (2021)

Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)
por: Landgren, C. Ola, et al.
Publicado: (2020)

Enacting research methods in information systems
por: Willcocks, Leslie P, et al.
Publicado: (2016)

Enacting research methods in information systems
por: Willcocks, Leslie P, et al.
Publicado: (2016)

Enacting research methods in information systems
por: Willcocks, Leslie P, et al.
Publicado: (2016)

The body social: an enactive approach to the self
por: Kyselo, Miriam
Publicado: (2014)

An Enactive-Ecological Approach to Information and Uncertainty
por: de Carvalho, Eros Moreira, et al.
Publicado: (2020)

Enacting Metaphors in Systemic Collaborative Therapy
por: Rucińska, Zuzanna, et al.
Publicado: (2022)

Enactive and simondonian reflections on mental disorders
por: García, Enara, et al.
Publicado: (2022)

Integration and Causality in Enactive Approaches to Psychiatry
por: Gallagher, Shaun
Publicado: (2022)

The Recently Enacted Law of New Jersey
Publicado: (1898)

Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia
por: Kawahara, Takashi, et al.
Publicado: (2019)

(125)Iodine monotherapy for Japanese men with low- and intermediate-risk prostate cancer: outcomes after 5 years of follow-up
por: Sekiguchi, Akane, et al.
Publicado: (2014)

High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center
por: Johansson, Bengt, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o4urilh159luh0c93eagroe9cq